ロード中...
Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
In the studies reported here we have used topoisomerase II as a model system for analyzing the factors that determine the sites of action for DNA-binding proteins in vivo. To localize topoisomerase II sites in vivo we used an inhibitor of the purified enzyme, the antitumor drug VM-26. This drug stab...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1991
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC361479/ https://ncbi.nlm.nih.gov/pubmed/1656219 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|